Brief: Alimera Announces Approval And Pricing Granted For Iluvien® For Uveitis In Italy
08/07/2022 13:45
July 8 (Reuters) - Alimera Sciences Inc ALIM.O :
* ALIMERA ANNOUNCES APPROVAL AND PRICING GRANTED FOR
ILUVIEN® FOR
UVEITIS IN ITALY
Source text for Eikon: ID:nGNX4ZhGhj
Further company coverage: ALIM.O
Recent news on Alimera Sciences
See all newsBrief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Brief: Alimera Sciences Files Lawsuit To Compel ANI To Close Merger